BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du K, Li S, Li C, Li P, Miao C, Luo T, Qiu B, Ding W. Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply. Acta Biomater 2021;134:228-39. [PMID: 34265474 DOI: 10.1016/j.actbio.2021.07.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Gharib G, Bütün İ, Muganlı Z, Kozalak G, Namlı İ, Sarraf SS, Ahmadi VE, Toyran E, van Wijnen AJ, Koşar A. Biomedical Applications of Microfluidic Devices: A Review. Biosensors 2022;12:1023. [DOI: 10.3390/bios12111023] [Reference Citation Analysis]
2 Liu M, Xiang Y, Yang Y, Long X, Xiao Z, Nan Y, Jiang Y, Qiu Y, Huang Q, Ai K. State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC. Biosensors and Bioelectronics 2022. [DOI: 10.1016/j.bios.2022.114758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kanabekova P, Kadyrova A, Kulsharova G. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro. Micromachines 2022;13:428. [DOI: 10.3390/mi13030428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
4 Bendre A, Bhat MP, Lee K, Altalhi T, Alruqi MA, Kurkuri M. Recent developments in microfluidic technology for synthesis and toxicity-efficiency studies of biomedical nanomaterials. Materials Today Advances 2022;13:100205. [DOI: 10.1016/j.mtadv.2022.100205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Ramos MJ, Bandiera L, Menolascina F, Fallowfield JA. In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications. iScience 2022;25:103549. [PMID: 34977507 DOI: 10.1016/j.isci.2021.103549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Huang D, Zhang X, Fu X, Zu Y, Sun W, Zhao Y. Liver spheroids on chips as emerging platforms for drug screening. Engineered Regeneration 2021;2:246-56. [DOI: 10.1016/j.engreg.2021.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]